Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$14.99 - $32.65 $4.67 Million - $10.2 Million
-311,313 Reduced 34.02%
603,762 $9.05 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $802,686 - $1.24 Million
26,972 Added 3.04%
915,075 $29.7 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $539,278 - $818,190
14,158 Added 1.62%
888,103 $34.8 Million
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $9.49 Million - $13.2 Million
234,050 Added 36.58%
873,945 $46.2 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $6.14 Million - $8.17 Million
166,036 Added 35.04%
639,895 $28.8 Million
Q2 2022

Aug 12, 2022

BUY
$28.03 - $45.8 $5.35 Million - $8.74 Million
190,913 Added 67.47%
473,859 $17.2 Million
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $175,673 - $264,712
6,008 Added 2.17%
282,946 $11.7 Million
Q4 2021

Feb 11, 2022

BUY
$39.32 - $61.61 $173,243 - $271,453
4,406 Added 1.62%
276,938 $11.8 Million
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $794,420 - $1.19 Million
18,055 Added 7.09%
272,532 $15 Million
Q2 2021

Aug 13, 2021

SELL
$44.66 - $63.06 $4.81 Million - $6.79 Million
-107,733 Reduced 29.74%
254,477 $12.2 Million
Q1 2021

May 12, 2021

BUY
$46.31 - $62.7 $3.47 Million - $4.69 Million
74,828 Added 26.04%
362,210 $18.3 Million
Q4 2020

Feb 12, 2021

SELL
$55.51 - $69.94 $42,631 - $53,713
-768 Reduced 0.27%
287,382 $18.1 Million
Q3 2020

Nov 12, 2020

BUY
$42.19 - $69.61 $605,932 - $999,738
14,362 Added 5.25%
288,150 $19.4 Million
Q2 2020

Aug 12, 2020

BUY
$27.55 - $43.28 $3.5 Million - $5.5 Million
127,006 Added 86.53%
273,788 $11.5 Million
Q1 2020

May 11, 2020

BUY
$23.16 - $47.8 $381,584 - $787,552
16,476 Added 12.64%
146,782 $4.62 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $3.64 Million - $5.26 Million
130,306 New
130,306 $5.26 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.